Clinical Perspective on Human Immunodeficiency Virus Care of Ukrainian War Refugees in Poland

The Russian invasion of Ukraine forced migration for safety, protection, and assistance. Poland is the primary sheltering country for Ukrainian refugees, providing support including medical care, which resulted in the rapid ∼15% increase in the number of followed-up people with human immunodeficienc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2023-05, Vol.76 (10), p.1708
Hauptverfasser: Parczewski, Miłosz, Jabłonowska, Elżbieta, Wójcik-Cichy, Kamila, Zhyvytsia, Dmytro, Witak-Jędra, Magdalena, Leszczyszyn-Pynka, Magdalena, Aksak-Wąs, Bogusz, Siwak, Ewa, Cielniak, Iwona, Olczak, Anita, Szymczak, Aleksandra, Szetela, Bartosz, Bociąga-Jasik, Monika, Kalinowska-Nowak, Anna, Mularska, Elżbieta, Witor, Adam, Jakubowski, Paweł, Hlebowicz, Maria, Rozpłochowski, Błażej, Łojewski, Władysław, Scheibe, Kaja, Serwin, Karol
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 10
container_start_page 1708
container_title Clinical infectious diseases
container_volume 76
creator Parczewski, Miłosz
Jabłonowska, Elżbieta
Wójcik-Cichy, Kamila
Zhyvytsia, Dmytro
Witak-Jędra, Magdalena
Leszczyszyn-Pynka, Magdalena
Aksak-Wąs, Bogusz
Siwak, Ewa
Cielniak, Iwona
Olczak, Anita
Szymczak, Aleksandra
Szetela, Bartosz
Bociąga-Jasik, Monika
Kalinowska-Nowak, Anna
Mularska, Elżbieta
Witor, Adam
Jakubowski, Paweł
Hlebowicz, Maria
Rozpłochowski, Błażej
Łojewski, Władysław
Scheibe, Kaja
Serwin, Karol
description The Russian invasion of Ukraine forced migration for safety, protection, and assistance. Poland is the primary sheltering country for Ukrainian refugees, providing support including medical care, which resulted in the rapid ∼15% increase in the number of followed-up people with human immunodeficiency virus (HIV) (PWH) in the country. Here, we present the national experience on HIV care provided for refugees from Ukraine. Clinical, antiretroviral, immunological, and virologic data from 955 Ukrainian PWH entering care in Poland since February 2022 were analyzed. The dataset included both antiretroviral-treated (n = 851) and newly diagnosed (n = 104) patients. In 76 cases, protease/reverse transcriptase/integrase sequencing was performed to identify drug resistance and subtype. Most (70.05%) of the patients were female, with a predominance of heterosexual (70.3%) transmissions. Anti-hepatitis C antibody and hepatitis B antigen were present in 28.7% and 2.9% of the patients, respectively. A history of tuberculosis was reported in 10.1% of cases. Among previously treated patients, the viral suppression rate was 89.6%; 77.3% of newly HIV diagnosed cases were diagnosed late (with lymphocyte CD4 count
doi_str_mv 10.1093/cid/ciad116
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_37253127</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>37253127</sourcerecordid><originalsourceid>FETCH-LOGICAL-p108t-2423f0229cc7bac96240b265ec5a6e093aebd24f8885704bc38f026b7a1562943</originalsourceid><addsrcrecordid>eNo1j11LwzAYhYMgbk6vvJf8gWo-mqS9lKJuMHCI0ysZb5M3Em2zkq7C_r0B9eJwbp5z4CHkirMbzmp5a4PLAce5PiFzrqQptKr5jJyP4ydjnFdMnZGZNEJJLsycvDddiMFCRzeYxgHtIXwj3Ue6nHqIdNX3U9w79MEGjPZIX0OaRtpAypCn268EeZ7BN0j0Gf30gTjSEOlm30F0F-TUQzfi5V8vyPbh_qVZFuunx1Vzty4GzqpDIUohPROitta0YGstStYKrdAq0Ji9AFsnSl9VlTKsbK2sMq5bA1xpUZdyQa5_f4ep7dHthhR6SMfdv6f8AWlNUvE</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Clinical Perspective on Human Immunodeficiency Virus Care of Ukrainian War Refugees in Poland</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Parczewski, Miłosz ; Jabłonowska, Elżbieta ; Wójcik-Cichy, Kamila ; Zhyvytsia, Dmytro ; Witak-Jędra, Magdalena ; Leszczyszyn-Pynka, Magdalena ; Aksak-Wąs, Bogusz ; Siwak, Ewa ; Cielniak, Iwona ; Olczak, Anita ; Szymczak, Aleksandra ; Szetela, Bartosz ; Bociąga-Jasik, Monika ; Kalinowska-Nowak, Anna ; Mularska, Elżbieta ; Witor, Adam ; Jakubowski, Paweł ; Hlebowicz, Maria ; Rozpłochowski, Błażej ; Łojewski, Władysław ; Scheibe, Kaja ; Serwin, Karol</creator><creatorcontrib>Parczewski, Miłosz ; Jabłonowska, Elżbieta ; Wójcik-Cichy, Kamila ; Zhyvytsia, Dmytro ; Witak-Jędra, Magdalena ; Leszczyszyn-Pynka, Magdalena ; Aksak-Wąs, Bogusz ; Siwak, Ewa ; Cielniak, Iwona ; Olczak, Anita ; Szymczak, Aleksandra ; Szetela, Bartosz ; Bociąga-Jasik, Monika ; Kalinowska-Nowak, Anna ; Mularska, Elżbieta ; Witor, Adam ; Jakubowski, Paweł ; Hlebowicz, Maria ; Rozpłochowski, Błażej ; Łojewski, Władysław ; Scheibe, Kaja ; Serwin, Karol</creatorcontrib><description>The Russian invasion of Ukraine forced migration for safety, protection, and assistance. Poland is the primary sheltering country for Ukrainian refugees, providing support including medical care, which resulted in the rapid ∼15% increase in the number of followed-up people with human immunodeficiency virus (HIV) (PWH) in the country. Here, we present the national experience on HIV care provided for refugees from Ukraine. Clinical, antiretroviral, immunological, and virologic data from 955 Ukrainian PWH entering care in Poland since February 2022 were analyzed. The dataset included both antiretroviral-treated (n = 851) and newly diagnosed (n = 104) patients. In 76 cases, protease/reverse transcriptase/integrase sequencing was performed to identify drug resistance and subtype. Most (70.05%) of the patients were female, with a predominance of heterosexual (70.3%) transmissions. Anti-hepatitis C antibody and hepatitis B antigen were present in 28.7% and 2.9% of the patients, respectively. A history of tuberculosis was reported in 10.1% of cases. Among previously treated patients, the viral suppression rate was 89.6%; 77.3% of newly HIV diagnosed cases were diagnosed late (with lymphocyte CD4 count &lt;350 cells/μL or AIDS). The A6 variant was observed in 89.0% of sequences. Transmitted mutations in the reverse transcriptase were found in 15.4% treatment-naive cases. Two patients with treatment failure exhibited multiclass drug resistance. Migration from Ukraine influences the characteristics of HIV epidemics in Europe, with an increase in the proportion of women and hepatitis C coinfected patients. Antiretroviral treatment efficacy among previously treated refugees was high, with new HIV cases frequently diagnosed late. The A6 subtype was the most common variant.</description><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1093/cid/ciad116</identifier><identifier>PMID: 37253127</identifier><language>eng</language><publisher>United States</publisher><subject>Anti-HIV Agents - therapeutic use ; Anti-Retroviral Agents - therapeutic use ; Female ; HIV Infections - drug therapy ; HIV Infections - epidemiology ; Humans ; Male ; Poland - epidemiology ; Refugees ; RNA-Directed DNA Polymerase - therapeutic use</subject><ispartof>Clinical infectious diseases, 2023-05, Vol.76 (10), p.1708</ispartof><rights>The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-1869-1084</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37253127$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Parczewski, Miłosz</creatorcontrib><creatorcontrib>Jabłonowska, Elżbieta</creatorcontrib><creatorcontrib>Wójcik-Cichy, Kamila</creatorcontrib><creatorcontrib>Zhyvytsia, Dmytro</creatorcontrib><creatorcontrib>Witak-Jędra, Magdalena</creatorcontrib><creatorcontrib>Leszczyszyn-Pynka, Magdalena</creatorcontrib><creatorcontrib>Aksak-Wąs, Bogusz</creatorcontrib><creatorcontrib>Siwak, Ewa</creatorcontrib><creatorcontrib>Cielniak, Iwona</creatorcontrib><creatorcontrib>Olczak, Anita</creatorcontrib><creatorcontrib>Szymczak, Aleksandra</creatorcontrib><creatorcontrib>Szetela, Bartosz</creatorcontrib><creatorcontrib>Bociąga-Jasik, Monika</creatorcontrib><creatorcontrib>Kalinowska-Nowak, Anna</creatorcontrib><creatorcontrib>Mularska, Elżbieta</creatorcontrib><creatorcontrib>Witor, Adam</creatorcontrib><creatorcontrib>Jakubowski, Paweł</creatorcontrib><creatorcontrib>Hlebowicz, Maria</creatorcontrib><creatorcontrib>Rozpłochowski, Błażej</creatorcontrib><creatorcontrib>Łojewski, Władysław</creatorcontrib><creatorcontrib>Scheibe, Kaja</creatorcontrib><creatorcontrib>Serwin, Karol</creatorcontrib><title>Clinical Perspective on Human Immunodeficiency Virus Care of Ukrainian War Refugees in Poland</title><title>Clinical infectious diseases</title><addtitle>Clin Infect Dis</addtitle><description>The Russian invasion of Ukraine forced migration for safety, protection, and assistance. Poland is the primary sheltering country for Ukrainian refugees, providing support including medical care, which resulted in the rapid ∼15% increase in the number of followed-up people with human immunodeficiency virus (HIV) (PWH) in the country. Here, we present the national experience on HIV care provided for refugees from Ukraine. Clinical, antiretroviral, immunological, and virologic data from 955 Ukrainian PWH entering care in Poland since February 2022 were analyzed. The dataset included both antiretroviral-treated (n = 851) and newly diagnosed (n = 104) patients. In 76 cases, protease/reverse transcriptase/integrase sequencing was performed to identify drug resistance and subtype. Most (70.05%) of the patients were female, with a predominance of heterosexual (70.3%) transmissions. Anti-hepatitis C antibody and hepatitis B antigen were present in 28.7% and 2.9% of the patients, respectively. A history of tuberculosis was reported in 10.1% of cases. Among previously treated patients, the viral suppression rate was 89.6%; 77.3% of newly HIV diagnosed cases were diagnosed late (with lymphocyte CD4 count &lt;350 cells/μL or AIDS). The A6 variant was observed in 89.0% of sequences. Transmitted mutations in the reverse transcriptase were found in 15.4% treatment-naive cases. Two patients with treatment failure exhibited multiclass drug resistance. Migration from Ukraine influences the characteristics of HIV epidemics in Europe, with an increase in the proportion of women and hepatitis C coinfected patients. Antiretroviral treatment efficacy among previously treated refugees was high, with new HIV cases frequently diagnosed late. The A6 subtype was the most common variant.</description><subject>Anti-HIV Agents - therapeutic use</subject><subject>Anti-Retroviral Agents - therapeutic use</subject><subject>Female</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - epidemiology</subject><subject>Humans</subject><subject>Male</subject><subject>Poland - epidemiology</subject><subject>Refugees</subject><subject>RNA-Directed DNA Polymerase - therapeutic use</subject><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j11LwzAYhYMgbk6vvJf8gWo-mqS9lKJuMHCI0ysZb5M3Em2zkq7C_r0B9eJwbp5z4CHkirMbzmp5a4PLAce5PiFzrqQptKr5jJyP4ydjnFdMnZGZNEJJLsycvDddiMFCRzeYxgHtIXwj3Ue6nHqIdNX3U9w79MEGjPZIX0OaRtpAypCn268EeZ7BN0j0Gf30gTjSEOlm30F0F-TUQzfi5V8vyPbh_qVZFuunx1Vzty4GzqpDIUohPROitta0YGstStYKrdAq0Ji9AFsnSl9VlTKsbK2sMq5bA1xpUZdyQa5_f4ep7dHthhR6SMfdv6f8AWlNUvE</recordid><startdate>20230524</startdate><enddate>20230524</enddate><creator>Parczewski, Miłosz</creator><creator>Jabłonowska, Elżbieta</creator><creator>Wójcik-Cichy, Kamila</creator><creator>Zhyvytsia, Dmytro</creator><creator>Witak-Jędra, Magdalena</creator><creator>Leszczyszyn-Pynka, Magdalena</creator><creator>Aksak-Wąs, Bogusz</creator><creator>Siwak, Ewa</creator><creator>Cielniak, Iwona</creator><creator>Olczak, Anita</creator><creator>Szymczak, Aleksandra</creator><creator>Szetela, Bartosz</creator><creator>Bociąga-Jasik, Monika</creator><creator>Kalinowska-Nowak, Anna</creator><creator>Mularska, Elżbieta</creator><creator>Witor, Adam</creator><creator>Jakubowski, Paweł</creator><creator>Hlebowicz, Maria</creator><creator>Rozpłochowski, Błażej</creator><creator>Łojewski, Władysław</creator><creator>Scheibe, Kaja</creator><creator>Serwin, Karol</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><orcidid>https://orcid.org/0000-0003-1869-1084</orcidid></search><sort><creationdate>20230524</creationdate><title>Clinical Perspective on Human Immunodeficiency Virus Care of Ukrainian War Refugees in Poland</title><author>Parczewski, Miłosz ; Jabłonowska, Elżbieta ; Wójcik-Cichy, Kamila ; Zhyvytsia, Dmytro ; Witak-Jędra, Magdalena ; Leszczyszyn-Pynka, Magdalena ; Aksak-Wąs, Bogusz ; Siwak, Ewa ; Cielniak, Iwona ; Olczak, Anita ; Szymczak, Aleksandra ; Szetela, Bartosz ; Bociąga-Jasik, Monika ; Kalinowska-Nowak, Anna ; Mularska, Elżbieta ; Witor, Adam ; Jakubowski, Paweł ; Hlebowicz, Maria ; Rozpłochowski, Błażej ; Łojewski, Władysław ; Scheibe, Kaja ; Serwin, Karol</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p108t-2423f0229cc7bac96240b265ec5a6e093aebd24f8885704bc38f026b7a1562943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Anti-HIV Agents - therapeutic use</topic><topic>Anti-Retroviral Agents - therapeutic use</topic><topic>Female</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - epidemiology</topic><topic>Humans</topic><topic>Male</topic><topic>Poland - epidemiology</topic><topic>Refugees</topic><topic>RNA-Directed DNA Polymerase - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Parczewski, Miłosz</creatorcontrib><creatorcontrib>Jabłonowska, Elżbieta</creatorcontrib><creatorcontrib>Wójcik-Cichy, Kamila</creatorcontrib><creatorcontrib>Zhyvytsia, Dmytro</creatorcontrib><creatorcontrib>Witak-Jędra, Magdalena</creatorcontrib><creatorcontrib>Leszczyszyn-Pynka, Magdalena</creatorcontrib><creatorcontrib>Aksak-Wąs, Bogusz</creatorcontrib><creatorcontrib>Siwak, Ewa</creatorcontrib><creatorcontrib>Cielniak, Iwona</creatorcontrib><creatorcontrib>Olczak, Anita</creatorcontrib><creatorcontrib>Szymczak, Aleksandra</creatorcontrib><creatorcontrib>Szetela, Bartosz</creatorcontrib><creatorcontrib>Bociąga-Jasik, Monika</creatorcontrib><creatorcontrib>Kalinowska-Nowak, Anna</creatorcontrib><creatorcontrib>Mularska, Elżbieta</creatorcontrib><creatorcontrib>Witor, Adam</creatorcontrib><creatorcontrib>Jakubowski, Paweł</creatorcontrib><creatorcontrib>Hlebowicz, Maria</creatorcontrib><creatorcontrib>Rozpłochowski, Błażej</creatorcontrib><creatorcontrib>Łojewski, Władysław</creatorcontrib><creatorcontrib>Scheibe, Kaja</creatorcontrib><creatorcontrib>Serwin, Karol</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Parczewski, Miłosz</au><au>Jabłonowska, Elżbieta</au><au>Wójcik-Cichy, Kamila</au><au>Zhyvytsia, Dmytro</au><au>Witak-Jędra, Magdalena</au><au>Leszczyszyn-Pynka, Magdalena</au><au>Aksak-Wąs, Bogusz</au><au>Siwak, Ewa</au><au>Cielniak, Iwona</au><au>Olczak, Anita</au><au>Szymczak, Aleksandra</au><au>Szetela, Bartosz</au><au>Bociąga-Jasik, Monika</au><au>Kalinowska-Nowak, Anna</au><au>Mularska, Elżbieta</au><au>Witor, Adam</au><au>Jakubowski, Paweł</au><au>Hlebowicz, Maria</au><au>Rozpłochowski, Błażej</au><au>Łojewski, Władysław</au><au>Scheibe, Kaja</au><au>Serwin, Karol</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Perspective on Human Immunodeficiency Virus Care of Ukrainian War Refugees in Poland</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clin Infect Dis</addtitle><date>2023-05-24</date><risdate>2023</risdate><volume>76</volume><issue>10</issue><spage>1708</spage><pages>1708-</pages><eissn>1537-6591</eissn><abstract>The Russian invasion of Ukraine forced migration for safety, protection, and assistance. Poland is the primary sheltering country for Ukrainian refugees, providing support including medical care, which resulted in the rapid ∼15% increase in the number of followed-up people with human immunodeficiency virus (HIV) (PWH) in the country. Here, we present the national experience on HIV care provided for refugees from Ukraine. Clinical, antiretroviral, immunological, and virologic data from 955 Ukrainian PWH entering care in Poland since February 2022 were analyzed. The dataset included both antiretroviral-treated (n = 851) and newly diagnosed (n = 104) patients. In 76 cases, protease/reverse transcriptase/integrase sequencing was performed to identify drug resistance and subtype. Most (70.05%) of the patients were female, with a predominance of heterosexual (70.3%) transmissions. Anti-hepatitis C antibody and hepatitis B antigen were present in 28.7% and 2.9% of the patients, respectively. A history of tuberculosis was reported in 10.1% of cases. Among previously treated patients, the viral suppression rate was 89.6%; 77.3% of newly HIV diagnosed cases were diagnosed late (with lymphocyte CD4 count &lt;350 cells/μL or AIDS). The A6 variant was observed in 89.0% of sequences. Transmitted mutations in the reverse transcriptase were found in 15.4% treatment-naive cases. Two patients with treatment failure exhibited multiclass drug resistance. Migration from Ukraine influences the characteristics of HIV epidemics in Europe, with an increase in the proportion of women and hepatitis C coinfected patients. Antiretroviral treatment efficacy among previously treated refugees was high, with new HIV cases frequently diagnosed late. The A6 subtype was the most common variant.</abstract><cop>United States</cop><pmid>37253127</pmid><doi>10.1093/cid/ciad116</doi><orcidid>https://orcid.org/0000-0003-1869-1084</orcidid></addata></record>
fulltext fulltext
identifier EISSN: 1537-6591
ispartof Clinical infectious diseases, 2023-05, Vol.76 (10), p.1708
issn 1537-6591
language eng
recordid cdi_pubmed_primary_37253127
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects Anti-HIV Agents - therapeutic use
Anti-Retroviral Agents - therapeutic use
Female
HIV Infections - drug therapy
HIV Infections - epidemiology
Humans
Male
Poland - epidemiology
Refugees
RNA-Directed DNA Polymerase - therapeutic use
title Clinical Perspective on Human Immunodeficiency Virus Care of Ukrainian War Refugees in Poland
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T13%3A25%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Perspective%20on%20Human%20Immunodeficiency%20Virus%20Care%20of%20Ukrainian%20War%20Refugees%20in%20Poland&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Parczewski,%20Mi%C5%82osz&rft.date=2023-05-24&rft.volume=76&rft.issue=10&rft.spage=1708&rft.pages=1708-&rft.eissn=1537-6591&rft_id=info:doi/10.1093/cid/ciad116&rft_dat=%3Cpubmed%3E37253127%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/37253127&rfr_iscdi=true